Therefore, HGF/SF stimulation of colon cancer cells along the invasive front will trigger the acquisition of quasi-mesenchymal characteristics and the AS-driven switch from CD44v6 to CD44s, the latter unable to bind HGF and as such controlling the extension of EMT activation. The gene discussed is HGF; the disease is malignant colon neoplasm.